| Literature DB >> 36190692 |
Xiangyi Kong1, Wenjie Hu1,2, Yu Cui1, Jingchen Gao1, Xujin Yao1, Jinyang Ren1, Tao Lin1, Jiangdong Sun1, Yunyi Gao1, Xiaohua Li1, Hui Wang1, Huanting Li1, Fengyuan Che3, Qi Wan4,5.
Abstract
Propionic acid (PPA) is a critical metabolite involved in microbial fermentation, which functions to reduce fat production, inhibit inflammation, and reduce serum cholesterol levels. The role of PPA in the context of cerebral ischemia-reperfusion (I/R) injury has yet to be clarified. Increasing evidence indicate that transcranial direct-current stimulation (tDCS) is a safe approach that confers neuroprotection in cerebral ischemia injury. Here, we show that the levels of PPA were reduced in the ischemic brain following a rat cerebral I/R injury and in the cultured rat cortical neurons after oxygen-glucose deprivation (OGD), an in vitro model of ischemic injury. We found that the decreased levels of transporter protein monocarboxylate transporter-1 (MCT1) were responsible for the OGD-induced reduction of PPA. Supplementing PPA reduced ischemia-induced neuronal death after I/R. Moreover, our results revealed that the neuroprotective effect of PPA is mediated through downregulation of phosphatase PTEN and subsequent upregulation of Lon protease 1 (LONP1). We demonstrated that direct-current stimulation (DCS) increased MCT1 expression and PPA level in OGD-insulted neurons, while tDCS decreased the brain infarct volume in the MCAO rats via increasing the levels of MCT1 expression and PPA. This study supports a potential application of tDCS in ischemic stroke.Entities:
Keywords: Cerebral ischemic stroke; LONP1; Neuroprotection; Propionic acid; tDCS
Year: 2022 PMID: 36190692 DOI: 10.1007/s12035-022-03051-7
Source DB: PubMed Journal: Mol Neurobiol ISSN: 0893-7648 Impact factor: 5.682